Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 142

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 19
Chunk 142
---
892,527  
  Less: repayments of promissory note – related party of 8i                                                    ( 300,000  
  Proceeds from the Reverse Recapitalization                                                                   1,324,961  
  Less: unpaid deferred underwriting fee                                                                     ( 2,113,125  
  Less: unpaid transaction costs incurred by 8i                                                                ( 382,600  
  Less: payment and accrued expenses of transaction costs related to the Reverse Recapitalization            ( 1,305,580  
  Add: non-cash net assets assumed from 8i                                                                    14,387,803  
  Net contributions from issuance of ordinary shares upon the Reverse Recapitalization                       $11,911,459  

Note
5 - Discontinued operations

In
September 2023, the Board resolved on the plan to streamline its medical services practice, which was carried out through the entities
of KRHSG, EUDA PL, ZKTV PL, SEMA, ED PL, KR Hill PL, ZKT PL, KR Digital, and Zukihealth, as the Company is in the process of transitioning
its business to other medical service fields. The streamlining of the Company’s medical services practice was accounted for as
a discontinued operation because it represented a strategic shift that had a major effect on the Company’s operations and financial
results in accordance with ASC 205-20-45.

On
January 1, 2024, the Company lost control of SEMA, Euda PL, and its subsidiary ZKTV PL, while they were undergoing liquidation. Accordingly,
the Company deconsolidated SEMA, Euda PL and ZKTV PL from its consolidated financial statements effective as of that date.

On
December 30, 2024, the Company sold 100 1

EUDA
HEALTH HOLDINGS LIMITED AND SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

(In
U. S. dollars, unless stated otherwise)

Reconciliation
of the carrying amounts of major classes of assets and liabilities from discontinued operations in the consolidated balance sheets as
of December 31, 2024 and 2023 are as follows:

Schedule of discontinued operation of financial statements

                                                            December 31,      December 31,                 
                                                                                                           
                                                            2024              2023                         
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────
  ASSETS                                                                                                   
  CURRENT ASSETS